A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell.
A new study shows how an anticancer drug triggers an “outside in” signal that gets it sucked into a cancer cell. The work, published Jan. 29 in Nature Communications, reveals ...
Merck Sharp & Dohme LLC has identified targeted activator of cell kill (TACK) compounds acting as Gag polyprotein (HIV-1)/protein Pol dimerization inducers reported to be useful for the treatment of ...
A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell.